查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1509651

2024 年血球容積比測試設備全球市場報告

Hematocrit Test Devices Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

血球比容測試設備的市場規模預計在未來幾年將強勁成長。 2028年，這一數字將以6.6%的複合年成長率成長至59.8億美元。預測期內的預期成長包括貧血盛行率增加、血液疾病病例增加、老年人口增加、對健康和健身的日益關注、對心血管診斷設備的需求增加等。在此期間預計的主要趨勢包括引入最先進的解決方案、醫學科學的技術進步、高效和創新的新產品的創造、血細胞比容測試的技術發展以及整個醫療保健領域。

血液疾病案例的增加預計將在未來幾年推動血球容積比測試設備市場的擴張。血液疾病包括影響人體血液各種成分的疾病，例如紅血球、白血球、血小板和血漿。由於遺傳因素、環境污染和生活方式改變等因素的綜合作用，這些疾病變得越來越常見。血球容積比測試設備在測量全血中紅血球的體積分數方面發揮重要作用，為了解患者的血液學健康狀況提供了重要的見解。例如，美國癌症協會2024年1月發布的報告預測，2024年美國將新增約62,770例白血病新患者，預計死亡人數為23,670人。其中，預計將出現約 20,800 例新的急性骨髓性白血病(AML) 病例，主要影響成人，約 11,220 人死於 AML。因此，血液疾病的增加正在刺激血球容積比測試設備市場的成長。

血球容積比測試設備市場的主要企業正在創新產品線，提供有關血球的定量和定性資訊，例如全血球計數 (CBC) 血液分析儀。全血球計數 (CBC) 血液分析儀是一種自動化設備，用於測量和分析血液的各種成分，包括紅血球 (RBC)、白血球 (WBC) 和血小板。例如，2022年3月，中國醫療設備公司邁瑞醫療國際有限公司發表了BC-700血球計數器系列。此系列涵蓋全血球計數（CBC）和紅血球沉積速率（ESR）檢測，適合具有接近高級產品的先進診斷技術的中型實驗室。 BC-700系列包括BC-720、BC-760和BC-780等型號，是高階BC-6000系列的更緊湊版本，並採用邁瑞的SF Cube 3D分析技術。 SF Cube 技術利用螢光和對角雷射散射訊號來實現目標細胞的3D分析。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球血球比容測試設備市場：促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 全球血球容積比測試設備市場表現：規模與成長，2018-2023
  • 全球血球容積比測試設備市場預測：規模與成長，2023-2028，2033F

第6章 市場細分

  • 全球血球比容測試設備市場：按產品分類的性能和預測，2018-2023、2023-2028F、2033F
  • 血球容積比測試儀
  • 血球容積比測試分析儀
  • 試劑及耗材
  • 全球血球比容測試設備市場：按應用分類的性能和預測，2018-2023、2023-2028F、2033F
  • 貧血
  • 真性多血症
  • 先天性心臟疾病
  • 其他用途
  • 全球血球容積比測試設備市場：最終用戶的實際與預測，2018-2023、2023-2028F、2033F
  • 醫院及門診手術中心
  • 診所
  • 診斷和病理實驗室
  • 其他最終用戶

第 7 章 區域/國家分析

  • 全球血球容積比測試設備市場：按地區分類的表現與預測，2018-2023、2023-2028F、2033F
  • 全球血球比容測試設備市場：按國家、性能和預測，2018-2023、2023-2028F、2033F

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 血球比容檢測設備市場：競爭格局
  • 血球比容測試設備市場：公司簡介
    • F. Hoffmann-La Roche Ltd.
    • Merck & Co. Inc.
    • Bayer AG
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories

第31章 其他大型創新企業

  • Danaher Corporation
  • Siemens Healthcare GmbH
  • Becton, Dickinson and Company（BD）
  • Terumo Corporation
  • Beckman Coulter Inc.
  • Mindray Medical International Limited
  • bioMerieux SA
  • Sysmex Corporation
  • Horiba Ltd.
  • Nihon Kohden Corporation
  • Erba Mannheim
  • Heska Corporation
  • EKF Diagnostics Holding Plc.
  • Nova Biomedical Corporation
  • Boule Diagnostics AB

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄
Product Code: r18148

Hematocrit test devices are medical instruments utilized to measure the percentage of red blood cells (RBCs) in a person's total blood volume. These devices serve various purposes, including monitoring chronic conditions, preoperative assessments, detecting blood doping, screening blood donors, managing emergencies, and conducting research and clinical trials.

The primary types of hematocrit test devices include hematocrit test meters, hematocrit test analyzers, and reagents and consumables. A hematocrit (HCT) test meter is a point-of-care device employed to measure the percentage of red blood cells in whole blood. It finds applications in conditions such as anemia, polycythemia vera, congenital heart diseases, among others, and is utilized by various end-users, including hospitals and ambulatory surgical centers, clinics, diagnostic and pathology labs, among others.

The hematocrit test devices market research report is one of a series of new reports from The Business Research Company that provides hematocrit test devices market statistics, including hematocrit test devices industry global market size, regional shares, competitors with a hematocrit test devices market share, detailed hematocrit test devices market segments, market trends and opportunities, and any further data you may need to thrive in the hematocrit test devices industry. This hematocrit test devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hematocrit test devices market size has grown strongly in recent years. It will grow from $4.35 billion in 2023 to $4.63 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth observed during the historic period can be attributed to several factors, including increased awareness regarding anemia and deficiencies in iron and vitamins, a rise in the incidence of chronic illnesses, increased government funding, and population growth.

The hematocrit test devices market size is expected to see strong growth in the next few years. It will grow to $5.98 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth in the forecast period can be attributed to several factors, including the increasing prevalence of anemia, growing cases of blood disorders, a rise in the geriatric population, heightened focus on health and fitness, and a widening need for cardiovascular diagnostic equipment. Major trends expected during this period include the introduction of cutting-edge solutions, advancements in technology within the medical science field, creation of new efficient and innovative products, technical developments in hematocrit testing, and overall advancements in the healthcare sector.

The increasing instances of blood disorders are anticipated to drive the expansion of the hematocrit test devices market in the coming years. Blood disorders encompass conditions affecting the various components of human blood, such as red blood cells, white blood cells, platelets, and plasma. These disorders are becoming more prevalent due to a combination of factors including genetic factors, environmental pollution, and changes in lifestyle. Hematocrit test devices play a vital role in measuring the volume percentage of red blood cells in whole blood, offering essential insights into the patient's hematological well-being. For example, a report published by the American Cancer Society in January 2024 projects approximately 62,770 new cases of leukemia in the United States for 2024, leading to an estimated 23,670 deaths. Among these cases, around 20,800 new instances of acute myeloid leukemia (AML) are expected, predominantly affecting adults, with approximately 11,220 deaths attributed to AML, primarily occurring in adult patients. Thus, the rising occurrences of blood disorders are stimulating the growth of the hematocrit test devices market.

Leading companies in the hematocrit test device market are innovating their product offerings, such as complete blood count (CBC) hematology analyzers, to deliver both quantitative and qualitative information about blood cells. A complete blood count (CBC) hematology analyzer is an automated instrument utilized to measure and analyze various components of blood, including red blood cells (RBCs), white blood cells (WBCs), and platelets. For instance, in March 2022, Mindray Medical International Limited, a China-based medical device company, introduced the BC-700 hematology analyzer series. This series encompasses both complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests, catering to medium-volume laboratories with advanced diagnostic technologies akin to premium products. The BC-700 Series, including models such as BC-720, BC-760, and BC-780, is a more compact iteration of the high-end BC-6000 Series, featuring Mindray's SF Cube 3D analysis technology. Leveraging fluorescence and bi-angular laser scatter signals, the SF Cube technology enables three-dimensional analysis of target cells.

In June 2023, Mars Incorporated, a US-based packaged food products manufacturer, acquired Heska Corporation for $1.3 billion. With this acquisition, Heska now operates under Mars Petcare's Science & Diagnostics division, expanding its reach in diagnostics and technology. The integration facilitates accelerated research and development efforts while enhancing global access to pet healthcare solutions. Heska Corporation specializes in manufacturing hematocrit test devices.

Major companies operating in the hematocrit test devices market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton, Dickinson and Company (BD), Terumo Corporation, Beckman Coulter Inc., Mindray Medical International Limited, bioMerieux SA, Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Erba Mannheim, Heska Corporation, EKF Diagnostics Holding Plc., Nova Biomedical Corporation, Boule Diagnostics AB, Stanbio Laboratory Lp, Drucker Diagnostics, A. Menarini Diagnostics Srl, Sensa Core, Mikroscan Technologies Inc.

North America was the largest region in the hematocrit test devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hematocrit test devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hematocrit test devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hematocrit test devices market consists of sales of hematocrit centrifuges, test strips, capillary transfer tubes, and adapter kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hematocrit Test Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hematocrit test devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hematocrit test devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hematocrit test devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Hematocrit Test Meter; Hematocrit Test Analyzer; Reagents And Consumables
  • 2) By Application: Anemia; Polycythemia Vera; Congenital Heart Diseases; Other Applications
  • 3) By End-User: Hospitals And Ambulatory Surgical Centers; Clinics; Diagnostic And Pathology Labs; Other End-Users
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Bayer AG; Thermo Fisher Scientific Inc.; Abbott Laboratories
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hematocrit Test Devices Market Characteristics

3. Hematocrit Test Devices Market Trends And Strategies

4. Hematocrit Test Devices Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Hematocrit Test Devices Market Size and Growth

  • 5.1. Global Hematocrit Test Devices Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Hematocrit Test Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Hematocrit Test Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Hematocrit Test Devices Market Segmentation

  • 6.1. Global Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hematocrit Test Meter
  • Hematocrit Test Analyzer
  • Reagents And Consumables
  • 6.2. Global Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Anemia
  • Polycythemia Vera
  • Congenital Heart Diseases
  • Other Applications
  • 6.3. Global Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Ambulatory Surgical Centers
  • Clinics
  • Diagnostic And Pathology Labs
  • Other End-Users

7. Hematocrit Test Devices Market Regional And Country Analysis

  • 7.1. Global Hematocrit Test Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Hematocrit Test Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Hematocrit Test Devices Market

  • 8.1. Asia-Pacific Hematocrit Test Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Hematocrit Test Devices Market

  • 9.1. China Hematocrit Test Devices Market Overview
  • 9.2. China Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Hematocrit Test Devices Market

  • 10.1. India Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Hematocrit Test Devices Market

  • 11.1. Japan Hematocrit Test Devices Market Overview
  • 11.2. Japan Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Hematocrit Test Devices Market

  • 12.1. Australia Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Hematocrit Test Devices Market

  • 13.1. Indonesia Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Hematocrit Test Devices Market

  • 14.1. South Korea Hematocrit Test Devices Market Overview
  • 14.2. South Korea Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Hematocrit Test Devices Market

  • 15.1. Western Europe Hematocrit Test Devices Market Overview
  • 15.2. Western Europe Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Hematocrit Test Devices Market

  • 16.1. UK Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Hematocrit Test Devices Market

  • 17.1. Germany Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Hematocrit Test Devices Market

  • 18.1. France Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Hematocrit Test Devices Market

  • 19.1. Italy Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Hematocrit Test Devices Market

  • 20.1. Spain Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Hematocrit Test Devices Market

  • 21.1. Eastern Europe Hematocrit Test Devices Market Overview
  • 21.2. Eastern Europe Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Hematocrit Test Devices Market

  • 22.1. Russia Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Hematocrit Test Devices Market

  • 23.1. North America Hematocrit Test Devices Market Overview
  • 23.2. North America Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Hematocrit Test Devices Market

  • 24.1. USA Hematocrit Test Devices Market Overview
  • 24.2. USA Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Hematocrit Test Devices Market

  • 25.1. Canada Hematocrit Test Devices Market Overview
  • 25.2. Canada Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Hematocrit Test Devices Market

  • 26.1. South America Hematocrit Test Devices Market Overview
  • 26.2. South America Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Hematocrit Test Devices Market

  • 27.1. Brazil Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Hematocrit Test Devices Market

  • 28.1. Middle East Hematocrit Test Devices Market Overview
  • 28.2. Middle East Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Hematocrit Test Devices Market

  • 29.1. Africa Hematocrit Test Devices Market Overview
  • 29.2. Africa Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Hematocrit Test Devices Market Competitive Landscape And Company Profiles

  • 30.1. Hematocrit Test Devices Market Competitive Landscape
  • 30.2. Hematocrit Test Devices Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck & Co. Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Bayer AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Thermo Fisher Scientific Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Abbott Laboratories
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Hematocrit Test Devices Market Other Major And Innovative Companies

  • 31.1. Danaher Corporation
  • 31.2. Siemens Healthcare GmbH
  • 31.3. Becton, Dickinson and Company (BD)
  • 31.4. Terumo Corporation
  • 31.5. Beckman Coulter Inc.
  • 31.6. Mindray Medical International Limited
  • 31.7. bioMerieux SA
  • 31.8. Sysmex Corporation
  • 31.9. Horiba Ltd.
  • 31.10. Nihon Kohden Corporation
  • 31.11. Erba Mannheim
  • 31.12. Heska Corporation
  • 31.13. EKF Diagnostics Holding Plc.
  • 31.14. Nova Biomedical Corporation
  • 31.15. Boule Diagnostics AB

32. Global Hematocrit Test Devices Market Competitive Benchmarking

33. Global Hematocrit Test Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Hematocrit Test Devices Market

35. Hematocrit Test Devices Market Future Outlook and Potential Analysis

  • 35.1 Hematocrit Test Devices Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Hematocrit Test Devices Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Hematocrit Test Devices Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer